Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.

Christie D, Shofer J, Millard SP, Li E, Demichele-Sweet MA, Weamer EA, Kamboh MI, Lopez OL, Sweet RA, Tsuang D.

Behav Brain Funct. 2012 Dec 27;8:62. doi: 10.1186/1744-9081-8-62.

2.

Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.

Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, Garman KS, Tampi RR, Gelernter J, van Dyck CH.

Neuropsychopharmacology. 2007 Jan;32(1):171-9. Epub 2006 Jul 12.

3.

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.

van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P.

Dement Geriatr Cogn Disord. 2007;23(1):42-6. Epub 2006 Oct 31.

PMID:
17077632
4.

ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.

Chang JB, Wang PN, Chen WT, Liu CY, Hong CJ, Lin KN, Liu TY, Chi CW, Liu HC.

Neurology. 2004 Sep 28;63(6):1105-7.

PMID:
15452311
5.

Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease.

Xing Y, Qin W, Li F, Jia XF, Jia J.

Dement Geriatr Cogn Disord. 2012;33(1):35-42. doi: 10.1159/000336600. Epub 2012 Mar 2.

PMID:
22398564
6.

Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.

Suh GH, Jung HY, Lee CU, Oh BH, Lee SK, Lee N, Kim J, Kee BS, Ko D, Kim YH, Ju YS, Hong I, Choi S; Korean Galantamine Study Group.

Dement Geriatr Cogn Disord. 2006;21(1):33-9. Epub 2005 Oct 25.

7.

Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.

Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.

Curr Alzheimer Res. 2014 Feb;11(2):137-44.

PMID:
24479631
8.

Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.

Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P.

Acta Psychiatr Scand. 2006 Jan;113(1):59-63. Erratum in: Acta Psychiatr Scand. 2005 Dec;112(6):481.

PMID:
16390371
9.

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

BMC Neurol. 2008 Apr 16;8:9. doi: 10.1186/1471-2377-8-9.

10.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

11.

Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.

Feldman B, Chapman J, Korczyn AD.

Acta Neurol Scand. 2006 Jan;113(1):14-7.

PMID:
16367893
12.

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56. doi: 10.1136/jnnp.2010.231555. Epub 2011 Apr 14.

PMID:
21493755
13.

Factors associated with psychotic symptoms in Alzheimer's disease.

Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H.

J Neurol Neurosurg Psychiatry. 1998 May;64(5):648-52.

14.

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.

Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C, Logroscino G, Solfrizzi V, Pilotto A.

Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7. Review.

PMID:
21763789
15.

Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG.

Int J Geriatr Psychiatry. 2000 Feb;15(2):99-107.

PMID:
10679840
16.

Psychotic symptoms in frontotemporal dementia: prevalence and review.

Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE.

Dement Geriatr Cogn Disord. 2008;25(3):206-11. doi: 10.1159/000113418. Epub 2008 Jan 17. Review.

17.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
18.

Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.

Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.

Neurology. 1996 Feb;46(2):413-9.

PMID:
8614504
19.

Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms.

Michels A, Multhammer M, Zintl M, Mendoza MC, Klünemann HH.

J Alzheimers Dis. 2012;28(1):25-32. doi: 10.3233/JAD-2011-110554.

PMID:
22246233
20.

Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementia.

Woods DL, Bushnell B, Kim H, Geschwind D, Cummings J.

Int Psychogeriatr. 2009 Aug;21(4):722-8. doi: 10.1017/S1041610209009235. Epub 2009 May 27.

PMID:
19470200
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk